Urinary UMOD excretion and chronic kidney disease in gout patients: Cross-sectional case-control study

Renal Failure

Volumn 33, Issue 2, 2011, Pages 164-168

  Wu, Chien Hsing ^a   Lee, Chien Te ^a   Lee, Chih Hsiung ^a   Cheng, Tien Tsai ^a   Chang, Hsueh Wen ^b   Lin, Eton ^c   Chuang, Feng Rong ^a   Yang, Hui Ping ^a   Chen, Ying Chou ^a   Wu, Chien Yi ^d   Chen, Chung Jen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c BOX HILL HOSPITAL   (Australia)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

chronic kidney disease (CKD); gout; TammHorsfall protein (THP); uromodulin (UMOD)

Indexed keywords

CREATININE; TAMM HORSFALL GLYCOPROTEIN; URIC ACID;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; FEMALE; GENE; GENOTYPE; GLOMERULUS FILTRATION RATE; GOUT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; URINE LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; GLOMERULAR FILTRATION RATE; GOUT; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; UROMODULIN; YOUNG ADULT;

EID: 79951963212     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.553302     Document Type: Article

References (21)

1. Sejdiu I, Torffvit O. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients. Scand J Urol Nephrol. 2008;42:168-174. (Pubitemid 351451008)
2. Torffvit O, Jorgensen PE, Kamper AL, et al. Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron. 1998;79:167-172. (Pubitemid 28256561)
3. Lynn KL, Marshall RD. Excretion of Tamm-Horsfall glycoprotein in renal disease. Clin Nephrol. 1984;22:253-257. (Pubitemid 15213064)
4. Tsai CY, Wu TH, Yu CL, Lu JY, Tsai YY. Increased excretions of beta2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis. Nephron. 2000;85:207-214.
5. Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricemic nephropathy. J Med Genet. 2002;39:882-892. (Pubitemid 36009149)
6. Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: Biology and clinical relevance. Am J Kidney Dis. 2003;42:658-676. (Pubitemid 37187366)
7. Mo L, Huang HY, Zhu XH, Shapiro E, Hasty DL, Wu XR. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation. Kidney Int. 2004;66:1159-1166. (Pubitemid 39121023)
8. Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR. Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol. 2004;286:F795-F802. (Pubitemid 38365099)
9. Chakraborty J, Below AA, Solaiman D. Tamm-Horsfall protein in patients with kidney damage and diabetes. Urol Res. 2004;32:79-83. (Pubitemid 38915394)
10. Bleyer AJ, Hart TC, Shihabi Z, Robins V, Hoyer JR. Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. Kidney Int. 2004;66:974-997.
11. Thornley C, Dawnay A, Cattell WR. Human Tamm-Horsfall glycoprotein: Urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay. Clin Sci (Lond). 1985;68:529-535. (Pubitemid 15103432)
12. Prajczer S, Heidenreich U, Pfaller W, Kotanko P, Lhotta K, Jennings P. Evidence for a role of uromodulin in chronic kidney disease progression. Nephrol Dial Transplant. 2010;25:1896-1903.
13. Kobayashi K, Fukuoka S. Conditions for solubilization of Tamm-Horsfall protein/uromodulin in human urine and establishment of a sensitive and accurate enzyme-linked immunosorbent assay (ELISA) method. Arch Biochem Biophys. 2001;388:113-120. (Pubitemid 32911569)
14. Richette P, Gout BT. Lancet. 2010;375:318-328.
15. Gaffo AL, Saag KG. Management of hyperuricemia and gout in CKD. Am J Kidney Dis. 2008;52:994-1009.
16. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13:2888-2897. (Pubitemid 35386908)
17. Tarng DC, Lin HY, Shyong ML, Wang JS, Yang WC, Huang TP. Renal function in gout patients. Am J Nephrol. 1995;15:31-37.
18. Kang DH, Nakagawa T. Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease. Semin Nephrol. 2005;25:43-49. (Pubitemid 40128148)
19. Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis. 1999;33:225-234. (Pubitemid 29072223)
20. Rindler MJ, Naik SS, Li N, Hoops TC, Peraldi MN. Uromodulin (Tamm-Horsfall glycoprotein/uromucoid) is a phosphatidylinositol-linked membrane protein. J Biol Chem. 1990;265:20784-20789. (Pubitemid 120014078)
21. Cavallone D, Malagolini N, Serafini-Cessi F. Mechanism of release of urinary Tamm-Horsfall glycoprotein from the kidney GPI-anchored counterpart. Biochem Biophys Res Commun. 2001;280:110-114. (Pubitemid 32917484)